BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/22/2022 1:26:05 AM | Browse: 215 | Download: 461
 |
Received |
|
2022-03-26 16:04 |
|
Peer-Review Started |
|
2022-03-26 16:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-11 17:24 |
|
Revised |
|
2022-06-20 21:37 |
|
Second Decision |
|
2022-08-12 03:02 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-08-18 00:25 |
|
Articles in Press |
|
2022-08-18 00:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-08-02 16:49 |
|
Typeset the Manuscript |
|
2022-08-24 06:05 |
|
Publish the Manuscript Online |
|
2022-09-22 01:26 |
| ISSN |
2150-5330 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
COVID-19 in patients with gastrointestinal stromal tumors: Recommendations for management and vaccination
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Violeta Snegarova, Dimitrina Miteva, Milena Gulinac, Monika Peshevska-Sekulovska, Hristiana Batselova and Tsvetelina Velikova |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| None |
|
|
| Corresponding Author |
Tsvetelina Velikova, MD, PhD, Assistant Professor, Chief Doctor, Department of Clinical Immunology, University Hospital Lozenetz, Kozyak 1 Street, Sofia 1407, Bulgaria. tsvelikova@medfac.mu-sofia.bg |
| Key Words |
Gastrointestinal stromal tumor; GIST; Cancer; COVID-19 vaccination; efficacy; Treatment strategy; Side effects |
| Core Tip |
Even under normal operating conditions, appropriate monitoring and treating patients with gastrointestinal stromal tumors (GISTs) require complex decision-making. Given the growing number of deaths worldwide and the failure of many countries to control the pandemic, vaccination against COVID-19 in these patients must be accelerated. The data show no significant difference in the efficacy of vaccines for the GIST population compared to that of other cancers. Vaccination between cycles of therapy and after waiting periods for patients with stem cell transplantation and immunoglobulin therapy can be used to reduce the risks while protecting patients from risk groups. |
| Publish Date |
2022-09-22 01:26 |
| Citation |
Snegarova V, Miteva D, Gulinac M, Peshevska-Sekulovska M, Batselova H, Velikova T. COVID-19 in patients with gastrointestinal stromal tumors: recommendations for managing and vaccination. World J Gastrointest Pathophysiol 2022;13(5): 170-177 |
| URL |
https://www.wjgnet.com/2150-5330/full/v13/i5/170.htm |
| DOI |
https://dx.doi.org/10.4291/wjgp.v13.i5.170 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
